Skip to main content

Advertisement

SpringerLink
Log in

Fracture Risk in Perimenopausal Women Treated with Beta-Blockers

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Î22-adrenergic receptors have been identified on human osteoblastic and osteoclastic cells, raising the question of a sympathetic regulation of bone metabolism. We investigated effects of treatment with Î2-adrenergic receptor antagonists (Î2-blockers) on bone turnover, bone mineral density (BMD), and fracture risk. Within the Danish Osteoporosis Prevention Study (DOPS) a population based, comprehensive cohort study of 2016 perimenopausal women, associations between treatment with Î2-blockers and bone turnover and BMD were assessed in a cross-sectional design at the start of study. Moreover, in a nested case-control design, fracture risk during the subsequent 5 years was assessed in relation to treatment with Î2-blockers at baseline. Multiple regression- and logistic regression-analyses were performed. Treatment with Î2-blockers was associated with a threefold increased fracture risk (ORadj 3.3; 95% CI: 1.1–9.4). Analyses on duration of treatment showed that women who had been treated for more than 8 years had a higher fracture risk (ORadj 5.3; 95% CI: 1.1–26.3) than those treated for less than 8 years (ORadj 2.4; 95% CI: 0.6–9.5). In addition, cross-sectional data showed 20% lower serum osteocalcin levels (an osteoblastic marker of bone formation) in women treated with Î2-blockers compared to untreated women (P < 0.001), whereas BMD at the lumbar spine and femoral neck did not differ between groups. Î2-blockers may decrease the activity of bone-forming cells and thereby increase fracture risk. However, confirmative studies and studies exploring mechanisms of action are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. RE Moore CK Smith CS Bailey EF Voelkel AH Tashjian SuffixJr (1993) ArticleTitleCharacterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture Bone Miner 23 301–315 Occurrence Handle1:CAS:528:DyaK2cXjtFKgsLc%3D Occurrence Handle7908582

    CAS  PubMed  Google Scholar 

  2. S Takeda F Elefteriou R Levasseur X Liu L Zhao KL Parker D Armstrong P Ducy G Karsenty (2002) ArticleTitleLeptin regulates bone formation via the sympathetic nervous system Cell 111 305–317 Occurrence Handle10.1016/S0092-8674(02)01049-8 Occurrence Handle1:CAS:528:DC%2BD38XovVakurk%3D Occurrence Handle12419242

    Article  CAS  PubMed  Google Scholar 

  3. A Togari (2002) ArticleTitleAdrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells Microsc Res Tech 58 77–84 Occurrence Handle10.1002/jemt.10121 Occurrence Handle1:CAS:528:DC%2BD38XmsVWrtr0%3D Occurrence Handle12203706

    Article  CAS  PubMed  Google Scholar 

  4. MS Herskovits IJ Singh (1984) ArticleTitleEffect of guanethidine-induced sympathectomy on osteoblastic activity in the rat femur evaluated by 3H-proline autoradiography Acta Anat (Basel) 120 151–155 Occurrence Handle1:STN:280:BiqD1MzjvFU%3D

    CAS  Google Scholar 

  5. B Minkowitz AL Boskey JM Lane HS Pearlman VJ Vigorita (1991) ArticleTitleEffects of propranolol on bone metabolism in the rat J Orthop Res 9 869–875 Occurrence Handle1:CAS:528:DyaK38XnsF2qug%3D%3D Occurrence Handle1919850

    CAS  PubMed  Google Scholar 

  6. T Takeuchi T Tsuboi M Arai A Togari (2001) ArticleTitleAdrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells Biochem Pharmacol 61 579–586 Occurrence Handle10.1016/S0006-2952(00)00591-8 Occurrence Handle1:CAS:528:DC%2BD3MXhsVOhs7s%3D Occurrence Handle11239501

    Article  CAS  PubMed  Google Scholar 

  7. RJ Majeska B Minkowitz W Bastian TA Einhorn (1992) ArticleTitleEffects of beta-adrenergic blockade in an osteoblast-like cell line J Orthop Res 10 379–384 Occurrence Handle1:CAS:528:DyaK38Xkt1Shu74%3D Occurrence Handle1349041

    CAS  PubMed  Google Scholar 

  8. J Cornish KE Callon U Bava et al. (2002) ArticleTitleLeptin directly regulates bone cell function in vitro and reduces bone fragility in vivo J Endocrinol 175 405–415 Occurrence Handle1:CAS:528:DC%2BD38Xptlaktbc%3D Occurrence Handle12429038

    CAS  PubMed  Google Scholar 

  9. P Ducy M Amling S Takeda et al. (2000) ArticleTitleLeptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 197–207 Occurrence Handle10.1016/S0092-8674(00)81558-5 Occurrence Handle1:CAS:528:DC%2BD3cXotFChsw%3D%3D Occurrence Handle10660043

    Article  CAS  PubMed  Google Scholar 

  10. L Mosekilde B Jastrup F Melsen B Lund OH Sørensen HE Nielsen H Yde (1984) ArticleTitleEffect of propranolol treatment on bone mass, bone mineral content, bone remodelling, parathyroid function and vitamin D metabolism in hyperthyroidism Eur J Clin Invest 14 96–102 Occurrence Handle1:STN:280:BiuB3snjsVM%3D Occurrence Handle6428910

    CAS  PubMed  Google Scholar 

  11. JA Pasco MJ Henry KM Sanders MA Kotowicz E Seeman GC Nicholson (2004) ArticleTitleBeta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study J Bone Miner Res 19 19–24 Occurrence Handle1:CAS:528:DC%2BD2cXnt1Khug%3D%3D Occurrence Handle14753732

    CAS  PubMed  Google Scholar 

  12. L Mosekilde AP Hermann NH Beck P Charles SP Nielsen OH Sorensen (1999) ArticleTitleThe Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women Maturitas 31 207–219 Occurrence Handle10.1016/S0378-5122(99)00006-7 Occurrence Handle1:STN:280:DyaK1M3ntFKguw%3D%3D Occurrence Handle10340280

    Article  CAS  PubMed  Google Scholar 

  13. AR Jadad (1998) Randomised Controlled Trials. A user’s guide BMJ Books London

    Google Scholar 

  14. P Vestergaard AP Hermann J Gram LB Jensen N Kolthoff B Abrahamsen C Brot P Eiken (1997) ArticleTitleImproving compliance with hormonal replacement therapy in primary osteoporosis prevention Maturitas 28 137–145 Occurrence Handle10.1016/S0378-5122(97)00076-5 Occurrence Handle1:STN:280:DyaK1c7ot1Oqsw%3D%3D Occurrence Handle9522321

    Article  CAS  PubMed  Google Scholar 

  15. A Moller (1989) Food composition tables. Publication No. SC3 The Danish National Food Agency Copenhagen

    Google Scholar 

  16. B Lund OH Sorensen (1979) ArticleTitleMeasurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population Scand J Clin Lab Invest 39 23–30 Occurrence Handle1:CAS:528:DyaE1MXlt1anurw%3D Occurrence Handle523951

    CAS  PubMed  Google Scholar 

  17. P Charles JW Poser L Mosekilde FT Jensen (1985) ArticleTitleEstimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion J Clin Invest 76 2254–2258 Occurrence Handle1:CAS:528:DyaL28XosVOrtw%3D%3D Occurrence Handle3878367

    CAS  PubMed  Google Scholar 

  18. K Brixen HK Nielsen EF Eriksen P Charles L Mosekilde (1989) ArticleTitleEfficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein Calcif Tissue Int 44 93–98 Occurrence Handle1:STN:280:BiaC3srms1Q%3D Occurrence Handle2783876

    CAS  PubMed  Google Scholar 

  19. A Pataki K Muller G Bilbe JR Green M Glatt (1996) ArticleTitleAnabolic effects of beta-2-agonists, formoterol and salbutamol on cancellous bone of ovariectomized (OVX) rat Bone 9 A116

    Google Scholar 

  20. C Olsson C Petersson A Nordquist (2003) ArticleTitleIncreased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up Acta Orthop Scand 74 714–717 Occurrence Handle10.1080/00016470310018252 Occurrence Handle14763704

    Article  PubMed  Google Scholar 

  21. O Johnell JA Kanis A Oden I Sernbo I Redlund-Johnell C Petterson C Laet ParticleDe B Jonsson (2004) ArticleTitleMortality after osteoporotic fractures Osteoporos Int 15 38–42 Occurrence Handle10.1007/s00198-003-1490-4 Occurrence Handle1:STN:280:DC%2BD2c%2FitlOhsw%3D%3D Occurrence Handle14593451

    Article  CAS  PubMed  Google Scholar 

  22. BM Ingle SM Hay HM Bottjer R Eastell (1999) ArticleTitleChanges in bone mass and bone turnover following ankle fracture Osteoporos Int 10 408–415 Occurrence Handle10.1007/s001980050247 Occurrence Handle1:STN:280:DC%2BD3c7ht1OjsQ%3D%3D Occurrence Handle10591839

    Article  CAS  PubMed  Google Scholar 

  23. DR Dirschl RC Henderson WC Oakley (1997) ArticleTitleAccelerated bone mineral loss following a hip fracture: a prospective longitudinal study Bone 21 79–82 Occurrence Handle10.1016/S8756-3282(97)00082-3 Occurrence Handle1:STN:280:ByiA2MnlslE%3D Occurrence Handle9213011

    Article  CAS  PubMed  Google Scholar 

  24. MM Petersen PM Gehrchen PK Nielsen B Lund (1997) ArticleTitleLoss of bone mineral of the hip assessed by DEXA following tibial shaft fractures Bone 20 491–495 Occurrence Handle10.1016/S8756-3282(97)00028-8 Occurrence Handle1:STN:280:ByiB1M%2FmtVY%3D Occurrence Handle9145248

    Article  CAS  PubMed  Google Scholar 

  25. JL Benovic C Staniszewski F Mayor SuffixJr MG Caron RJ Lefkowitz (1988) ArticleTitleBeta-adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation J Biol Chem 263 3893–3897 Occurrence Handle1:CAS:528:DyaL1cXhs1Wqu7k%3D Occurrence Handle2831211

    CAS  PubMed  Google Scholar 

  26. G Boguslawski LV Hale XP Yu RR Miles JE Onyia RF Santerre S Chandrasekhar (2000) ArticleTitleActivation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways J Biol Chem 275 999–1006 Occurrence Handle10.1074/jbc.275.2.999 Occurrence Handle1:CAS:528:DC%2BD3cXntleitg%3D%3D Occurrence Handle10625638

    Article  CAS  PubMed  Google Scholar 

  27. XP Yu S Chandrasekhar (1997) ArticleTitleParathyroid hormone (PTH 1-34) regulation of rat osteocalcin gene transcription Endocrinology 138 3085–3092 Occurrence Handle10.1210/en.138.8.3085 Occurrence Handle1:CAS:528:DyaK2sXkslSisLg%3D Occurrence Handle9231754

    Article  CAS  PubMed  Google Scholar 

  28. MJ Horwitz MB Tedesco C Gundberg A Garcia-Ocana AF Stewart (2003) ArticleTitleShort-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis J Clin Endocrinol Metab 88 569–575 Occurrence Handle10.1210/jc.2002-021122 Occurrence Handle1:CAS:528:DC%2BD3sXhtlChsb8%3D Occurrence Handle12574182

    Article  CAS  PubMed  Google Scholar 

  29. F Cosman J Nieves L Woelfert V Shen R Lindsay (1998) ArticleTitleAlendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women J Bone Miner Res 13 1051–1055 Occurrence Handle1:CAS:528:DyaK1cXjvFSmuro%3D Occurrence Handle9626638

    CAS  PubMed  Google Scholar 

  30. T Steinichel P Christiansen A Vesterby R Ullerup I Hessov LE Mosekilde F Melsen (2000) ArticleTitlePrimary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment Bone 26 535–543 Occurrence Handle10.1016/S8756-3282(00)00260-X Occurrence Handle10773596

    Article  PubMed  Google Scholar 

  31. M Kanatani T Sugimoto H Kaji K Ikeda K Chihara (2001) ArticleTitleSkeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism Eur J Endocrinol 144 263–269 Occurrence Handle1:CAS:528:DC%2BD3MXisFagtLw%3D Occurrence Handle11248746

    CAS  PubMed  Google Scholar 

  32. L Mortensen L Hyldstrup P Charles (1997) ArticleTitleEffect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis Eur J Endocrinol 136 52–60 Occurrence Handle1:CAS:528:DyaK2sXhslGmt7Y%3D Occurrence Handle9037127

    CAS  PubMed  Google Scholar 

  33. K Kruse U Kracht K Wohlfart U Kruse (1989) ArticleTitleBiochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment Eur J Pediatr 148 535–539 Occurrence Handle1:STN:280:BiaA3crmt1A%3D Occurrence Handle2744015

    CAS  PubMed  Google Scholar 

  34. K Tsuda I Nishio Y Masuyama (2001) ArticleTitleBone mineral density in women with essential hypertension Am J Hyperten 14 704–707 Occurrence Handle10.1016/S0895-7061(01)01303-6 Occurrence Handle1:STN:280:DC%2BD38%2FitF2isg%3D%3D

    Article  CAS  Google Scholar 

  35. DA Hanley JP Brown A Tenenhouse et al. (2003) ArticleTitleAssociations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study J Bone Miner Res 18 784–790 Occurrence Handle1:STN:280:DC%2BD3s7ls1Whtw%3D%3D Occurrence Handle12674340

    CAS  PubMed  Google Scholar 

  36. DT Felson D Sloutskis JJ Anderson JM Anthony DP Kiel (1991) ArticleTitleThiazide diuretics and the risk of hip fracture. Results from the Framingham Study JAMA 265 370–373 Occurrence Handle10.1001/jama.265.3.370 Occurrence Handle1:STN:280:By6D1c%2Fis1w%3D Occurrence Handle1984536

    Article  CAS  PubMed  Google Scholar 

  37. AZ LaCroix J Wienpahl LR White RB Wallace PA Scherr LK George J Cornoni Huntley AM Ostfeld (1990) ArticleTitleThiazide diuretic agents and the incidence of hip fracture N Engl J Med 322 286–290 Occurrence Handle1:STN:280:By%2BC3Mvjtlw%3D Occurrence Handle2296269

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Aarhus, Denmark

    Lars Rejnmark, Peter Vestergaard & Leif Mosekilde

  2. Dept. of Endocrinology, Odense University Hospital, Odense, Denmark

    Moustapha Kassem & Kim Brixen

  3. The Osteoporosis Research Centre, Hvidovre Hospital, Hvidovre, Denmark

    Bo Rud Christoffersen

  4. Dept. of Clinical Physiology and Nuclear Medicine, Hilleroed Hospital, Hilleroed, Denmark

    Niels Kolthoff

Authors
  1. Lars Rejnmark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Vestergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moustapha Kassem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Rud Christoffersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Niels Kolthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kim Brixen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Leif Mosekilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lars Rejnmark.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rejnmark, L., Vestergaard, P., Kassem, M. et al. Fracture Risk in Perimenopausal Women Treated with Beta-Blockers. Calcif Tissue Int 75, 365–372 (2004). https://doi.org/10.1007/s00223-004-0222-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-004-0222-x

Keywords

Search

Navigation